Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Atea Pharmaceuticals, Inc. (AVIR) had Cash Flow from Financial Activities of $0.26M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-45.44M |
|
-- |
|
-- |
|
$48.01M |
|
$-48.01M |
|
$2.62M |
|
$-45.39M |
|
$-45.39M |
|
$-45.44M |
|
$-45.44M |
|
$-45.44M |
|
$-45.44M |
|
$-48.01M |
|
$-48.48M |
|
79.20M |
|
79.20M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$263.20M |
|
$0.35M |
|
$3.88M |
|
$267.08M |
|
$33.37M |
|
-- |
|
-- |
|
$33.37M |
|
$233.71M |
|
$233.71M |
|
$233.71M |
|
80.03M |
|
| Cash Flow Statement Financials | |
$-46.39M |
|
$29.74M |
|
|
Cash Flow from Financial Activities |
$0.26M |
$95.71M |
|
$79.32M |
|
$-16.40M |
|
$3.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.44% |
|
-19.44% |
|
-17.01% |
|
-19.44% |
|
$2.92 |
|
$-0.59 |
|
$-0.59 |
|